Imagenetix Presents Data From Clinical study on Cetylated Fatty Acids Absorption and Metabolism at Experimental Biology 2003 Conference

by Imagenetix on April 14, 2003

San Diego based Imagenetix, Inc. www.imagenetix.net (OTCBB: IAGX) announces promising research on the bioavailability of a proprietary Imagenetix compound was detailed in a poster presentation at the Experimental Biology 2003 Conference in San Diego on Saturday, April 12. This compound is a proprietary fatty acid ester blend that has been shown in studies to significantly [...]

{ Comments on this entry are closed }

Imagenetix Files Patent on Genepril™

by Imagenetix on April 2, 2003

San Diego, CA – April 2, 2003 – Imagenetix, Inc. (OTC/BB: IAGX) announces the filing of a patent application with the U.S. Patent Office for its Genepril™ bioceutical composition. Imagenetix is seeking claims for the prevention and treatment of various types of arthritis and other inflammatory joint diseases as well as psoriasis, lupus, and cardiovascular [...]

{ Comments on this entry are closed }